gms | German Medical Science

76th Annual Meeting of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery

German Society of Oto-Rhino-Laryngology, Head and Neck Surgery

04.05. - 08.05.2005, Erfurt

Botulinum toxin for treatment of habitual snoring: a pilot study

Meeting Abstract

  • corresponding author Thomas Kühnel - HNO-Klinik der Universität Regensburg, Regensburg
  • Wilhelm Schulte-Mattler - Neurologie, Universität Regensburg, Regensburg
  • Thomas Neumann - HNO-Klinik der Universität Regensburg, Regensburg

Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie. 76. Jahresversammlung der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e.V.. Erfurt, 04.-08.05.2005. Düsseldorf, Köln: German Medical Science; 2005. Doc05hno431

The electronic version of this article is the complete one and can be found online at: http://www.egms.de/en/meetings/hno2005/05hno237.shtml

Published: September 22, 2005

© 2005 Kühnel et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.


Outline

Text

Snoring is a frequent condition, concerning appr. 40% of the male and 20% of the female population. Treatment of habitual snoring without impairment of the breathing pathway should comprise of minimal invasive means. Usually stiffening of vibratory tissue i.e. of the soft palate is offered. We hypothesize that active processes are involved in a subgroup of snorers. Therefore we utilized 30 MU of Dysport™ in 8 patients to paralyse half side of the soft palate for treatment of habitual snoring. Only patients who were recognized by means of electromyography to initiate snoring actively were selected for this therapy.

No severe adverse effects were observed, particularly not deterioration of respiratory parameters. Patients stated dullness of the soft palate for about one week. Snoring improved in 5 out of eight cases satisfactorily according to spouses’ interview answers: The frequency of snoring turned down to 60% of the initial value. Snoring index as calculated from polysomnography improved to 9,5% of the initial value.

We conclude that muscle activity is mandatory to initiate snoring in a subgroup of snorers. Treatment with Botulinum toxin offers an easy to perform, safe and minimal invasive therapy option.